{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:15:54Z","timestamp":1790291754454,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","award":["PPOIT-003"],"award-info":[{"award-number":["PPOIT-003"]}],"id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["115423"],"award-info":[{"award-number":["115423"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010882","name":"Australasian Society of Clinical Immunology and Allergy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jaip.2025.09.010","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T05:50:20Z","timestamp":1758606620000},"page":"3355-3363.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Participant Baseline Factors on Exposure-Adjusted Incidence of Treatment-Related Adverse Events During Peanut Oral Immunotherapy"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3889-5458","authenticated-orcid":false,"given":"Melanie","family":"Lloyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarabnoor Singh","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paxton","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Chebar","family":"Lozinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi L.K.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.09.010_bib1","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/all.15211","article-title":"Allergen immunotherapy and\/or biologicals for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"77","author":"de Silva","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.09.010_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12268","article-title":"Efficacy and safety of oral immunotherapy for peanut, cow's milk, and hen's egg allergy: a systematic review of randomized controlled trials","volume":"13","author":"Lodge","year":"2023","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.09.010_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/all.13124","article-title":"Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"72","author":"Nurmatov","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.09.010_bib4","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.09.010_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41598-019-56961-3","article-title":"Adverse events associated with peanut oral immunotherapy in children\u2013a systematic review and meta-analysis","volume":"10","author":"Grzeskowiak","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2025.09.010_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s40521-019-00205-2","article-title":"Risk factors for adverse reactions during OIT","volume":"6","author":"Patel","year":"2019","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2025.09.010_bib7","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.010_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaip.2013.10.001","article-title":"Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions","volume":"2","author":"Wasserman","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.010_bib9","article-title":"Risk factors associated with safety of preschool peanut oral immunotherapy","volume":"2","author":"Karunakaran","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2025.09.010_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2016.07.030","article-title":"Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy","volume":"139","author":"Virkud","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.010_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy","volume":"133","author":"Vickery","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.010_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.010_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2352-4642(22)00006-2","article-title":"Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial","volume":"6","author":"Loke","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaip.2025.09.010_bib14","volume":"10","author":"Lozinsky","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2025.09.010_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100753","article-title":"WAO consensus on DEfinition of food allergy SEverity (DEFASE)","volume":"16","author":"Arasi","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2025.09.010_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaci.2022.04.008","article-title":"The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study","volume":"150","author":"Peters","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.010_bib17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2222.2008.02978.x","article-title":"Food allergy QoL questionnaire for children aged 0\u201312 years: content, construct, and cross-cultural validity","volume":"38","author":"Dunn Galvin","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.09.010_bib18","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2023.01.033","article-title":"Endpoints and outcomes after immunotherapy for food allergy: what is meaningful for patients?","volume":"11","author":"Lloyd","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.010_bib19","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/cea.14225","article-title":"Information needs of patients considering oral immunotherapy for food allergy","volume":"52","author":"Mack","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.09.010_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1\u20133 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.09.010_bib21","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(19)30767-6","article-title":"Peanut oral immunotherapy: balancing benefits and risks for individuals","volume":"393","author":"Roberts","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.09.010_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaip.2021.10.070","article-title":"Advances, practical implementation, and unmet needs regarding oral immunotherapy for food allergy","volume":"10","author":"Perrett","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.010_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2016.08.010","article-title":"Omalizumab facilitates rapid oral desensitization for peanut allergy","volume":"139","author":"MacGinnitie","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.010_bib24","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"PALISADE Group of Clinical Investigators","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.09.010_bib25","first-page":"382","article-title":"Health-related quality of life in children with food allergy and their parents: a systematic review of the literature","volume":"24","author":"Morou","year":"2014","journal-title":"J Investig Allergol Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825009043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825009043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:06:45Z","timestamp":1778893605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825009043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2213219825009043"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.09.010","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Participant Baseline Factors on Exposure-Adjusted Incidence of Treatment-Related Adverse Events During Peanut Oral Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}